{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:53:01Z","timestamp":1794001981212,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-53916-9","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T20:50:50Z","timestamp":1735851050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Dengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protective"],"prefix":"10.1038","volume":"16","author":[{"given":"Camila D.","family":"Odio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jedas Veronica","family":"Daag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vinna","family":"Crisostomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3653-8975","authenticated-orcid":false,"given":"Charlie J.","family":"Voirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Coello Escoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Dahora Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4588-4914","authenticated-orcid":false,"given":"Rosemary A.","family":"Aogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick I.","family":"Mpingabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Raimundi Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Firdous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Abad Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristal An","family":"Agrupis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8875-5026","authenticated-orcid":false,"given":"Jacqueline","family":"Deen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3317-5950","authenticated-orcid":false,"given":"Aravinda M.","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2653-4460","authenticated-orcid":false,"given":"Michelle","family":"Ylade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-6758","authenticated-orcid":false,"given":"Leah C.","family":"Katzelnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"53916_CR1","unstructured":"WHO. WHO | Dengue guidelines, for diagnosis, treatment, prevention and control. http:\/\/www.who.int\/neglected_diseases\/resources\/9789241547871\/en\/ (2009)."},{"key":"53916_CR2","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","volume":"5","author":"TC Pierson","year":"2020","unstructured":"Pierson, T. C. & Diamond, M. S. The continued threat of emerging flaviviruses. Nat. Microbiol. 5, 796\u2013812 (2020).","journal-title":"Nat. Microbiol."},{"key":"53916_CR3","doi-asserted-by":"publisher","first-page":"14688","DOI":"10.1073\/pnas.1508114112","volume":"112","author":"V Duong","year":"2015","unstructured":"Duong, V. et al. Asymptomatic humans transmit dengue virus to mosquitoes. Proc. Natl. Acad. Sci. USA 112, 14688\u201314693 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"53916_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504\u2013507 (2013).","journal-title":"Nature"},{"key":"53916_CR5","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s40121-021-00470-2","volume":"10","author":"M Du","year":"2021","unstructured":"Du, M., Jing, W., Liu, M. & Liu, J. The global trends and regional differences in incidence of dengue infection from 1990 to 2019: An analysis from the global burden of disease study 2019. Infect. Dis. Ther. 10, 1625\u20131643 (2021).","journal-title":"Infect. Dis. Ther."},{"key":"53916_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","volume":"379","author":"S Sridhar","year":"2018","unstructured":"Sridhar, S. et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N. Engl. J. Med. 379, 327\u2013340 (2018).","journal-title":"N. Engl. J. Med."},{"key":"53916_CR7","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S2214-109X(23)00522-3","volume":"12","author":"V Tricou","year":"2024","unstructured":"Tricou, V. et al. Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4\u00b75-year results from a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Glob. Health 12, e257\u2013e270 (2024).","journal-title":"Lancet Glob. Health"},{"key":"53916_CR8","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1056\/NEJMp2211314","volume":"387","author":"PB Gilbert","year":"2022","unstructured":"Gilbert, P. B. et al. A covid-19 milestone attained \u2014 A correlate of protection for vaccines. N. Engl. J. Med. 387, 2203\u20132206 (2022).","journal-title":"N. Engl. J. Med."},{"key":"53916_CR9","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/cid\/cis238","volume":"54","author":"SA Plotkin","year":"2012","unstructured":"Plotkin, S. A. & Gilbert, P. B. Nomenclature for immune correlates of protection after vaccination. Clin. Infect. Dis. 54, 1615\u20131617 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"53916_CR10","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1016\/j.vaccine.2017.07.045","volume":"35","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick, L. C., Harris, E. & Participants in the Summit on Dengue Immune Correlates of Protection. Immune correlates of protection for dengue: State of the art and research agenda. Vaccine 35, 4659\u20134669 (2017).","journal-title":"Vaccine"},{"key":"53916_CR11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","volume":"17","author":"SA Plotkin","year":"2010","unstructured":"Plotkin, S. A. Correlates of protection induced by vaccination. Clin. Vaccin. Immunol. 17, 1055\u20131065 (2010).","journal-title":"Clin. Vaccin. Immunol."},{"key":"53916_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4269\/ajtmh.18-0534","volume":"101","author":"PB Gilbert","year":"2019","unstructured":"Gilbert, P. B. et al. Bridging efficacy of a tetravalent dengue vaccine from children\/adolescents to adults in highly endemic countries based on neutralizing antibody response. Am. J. Trop. Med. Hyg. 101, 164\u2013179 (2019).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"53916_CR13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/infdis\/jix609","volume":"217","author":"Z Moodie","year":"2018","unstructured":"Moodie, Z. et al. Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America. J. Infect. Dis. 217, 742\u2013753 (2018).","journal-title":"J. Infect. Dis."},{"key":"53916_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/infdis\/jiab342","volume":"225","author":"Y Huang","year":"2022","unstructured":"Huang, Y. et al. Analysis of neutralizing antibodies as a correlate of instantaneous risk of hospitalized dengue in placebo recipients of dengue vaccine efficacy trials. J. Infect. Dis. 225, 332\u2013340 (2022).","journal-title":"J. Infect. Dis."},{"key":"53916_CR15","doi-asserted-by":"publisher","first-page":"1081107","DOI":"10.3389\/fimmu.2022.1081107","volume":"13","author":"SA Plotkin","year":"2023","unstructured":"Plotkin, S. A. Recent updates on correlates of vaccine-induced protection. Front. Immunol. 13, 1081107 (2023).","journal-title":"Front. Immunol."},{"key":"53916_CR16","doi-asserted-by":"publisher","first-page":"e0005554","DOI":"10.1371\/journal.pntd.0005554","volume":"11","author":"B Patel","year":"2017","unstructured":"Patel, B. et al. Dissecting the human serum antibody response to secondary dengue virus infections. PLoS Negl. Trop. Dis. 11, e0005554 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"53916_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","volume":"8","author":"M Beltramello","year":"2010","unstructured":"Beltramello, M. et al. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8, 271\u2013283 (2010).","journal-title":"Cell Host Microbe"},{"key":"53916_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature14130","volume":"520","author":"A Rouvinski","year":"2015","unstructured":"Rouvinski, A. et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520, 109\u2013113 (2015).","journal-title":"Nature"},{"key":"53916_CR19","doi-asserted-by":"publisher","first-page":"eaaw9066","DOI":"10.1126\/scitranslmed.aaw9066","volume":"12","author":"S Maciejewski","year":"2020","unstructured":"Maciejewski, S. et al. Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality. Sci. Transl. Med. 12, eaaw9066 (2020).","journal-title":"Sci. Transl. Med."},{"key":"53916_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"W Dejnirattisai","year":"2015","unstructured":"Dejnirattisai, W. et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat. Immunol. 16, 170\u2013177 (2015).","journal-title":"Nat. Immunol."},{"key":"53916_CR21","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1128\/JVI.06335-11","volume":"86","author":"SA Smith","year":"2012","unstructured":"Smith, S. A. et al. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J. Virol. 86, 2665\u20132675 (2012).","journal-title":"J. Virol."},{"key":"53916_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1073\/pnas.1812055115","volume":"116","author":"R Raut","year":"2019","unstructured":"Raut, R. et al. Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies. Proc. Natl. Acad. Sci. USA 116, 227\u2013232 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"53916_CR23","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/S2214-109X(20)30392-2","volume":"9","author":"AL Lopez","year":"2021","unstructured":"Lopez, A. L. et al. Determining dengue virus serostatus by indirect IgG ELISA compared with focus reduction neutralisation test in children in Cebu, Philippines: a prospective population-based study. Lancet Glob. Health 9, e44\u2013e51 (2021).","journal-title":"Lancet Glob. Health"},{"key":"53916_CR24","doi-asserted-by":"publisher","first-page":"S1473","DOI":"10.1016\/S1473-3099(24)00099-9","volume":"24","author":"M Ylade","year":"2024","unstructured":"Ylade, M. et al. Effect of single-dose, live, attenuated dengue vaccine in children with or without previous dengue on risk of subsequent, virologically confirmed dengue in Cebu, the Philippines: a longitudinal, prospective, population-based cohort study. Lancet Infect. Dis. 24, S1473\u2013S3099 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"53916_CR25","doi-asserted-by":"publisher","first-page":"a029371","DOI":"10.1101\/cshperspect.a029371","volume":"10","author":"AM de Silva","year":"2018","unstructured":"de Silva, A. M. & Harris, E. Which Dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination? The path to a Dengue vaccine: Learning from human natural Dengue infection studies and vaccine trials. Cold Spring Harb. Perspect. Biol. 10, a029371 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"53916_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick, L. C. et al. Antibody-dependent enhancement of severe dengue disease in humans. Science 358, 929\u2013932 (2017).","journal-title":"Science"},{"key":"53916_CR27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1073\/pnas.1522136113","volume":"113","author":"LC Katzelnick","year":"2016","unstructured":"Katzelnick, L. C., Montoya, M., Gresh, L., Balmaseda, A. & Harris, E. Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort. Proc. Natl. Acad. Sci. USA 113, 728\u2013733 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"53916_CR28","doi-asserted-by":"publisher","first-page":"e00556","DOI":"10.1128\/JVI.00556-18","volume":"92","author":"WY Tsai","year":"2018","unstructured":"Tsai, W. Y. et al. Potent neutralizing human monoclonal antibodies preferentially target mature Dengue virus particles: Implication for novel strategy for Dengue vaccine. J. Virol. 92, e00556\u201318 (2018).","journal-title":"J. Virol."},{"key":"53916_CR29","doi-asserted-by":"publisher","first-page":"110930","DOI":"10.1016\/j.celrep.2022.110930","volume":"39","author":"EN Gallichotte","year":"2022","unstructured":"Gallichotte, E. N. et al. Vaccine-induced antibodies to contemporary strains of dengue virus type 4 show a mechanistic correlate of protective immunity. Cell Rep. 39, 110930 (2022).","journal-title":"Cell Rep."},{"key":"53916_CR30","doi-asserted-by":"publisher","first-page":"e147066","DOI":"10.1172\/JCI147066","volume":"131","author":"S Henein","year":"2021","unstructured":"Henein, S. et al. Dengue vaccine breakthrough infections reveal properties of neutralizing antibodies linked to protection. J. Clin. Invest. 131, e147066 (2021).","journal-title":"J. Clin. Invest."},{"key":"53916_CR31","doi-asserted-by":"publisher","first-page":"e0009258","DOI":"10.1371\/journal.pntd.0009258","volume":"15","author":"LJ White","year":"2021","unstructured":"White, L. J. et al. Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003). PLOS Negl. Trop. Dis. 15, e0009258 (2021).","journal-title":"PLOS Negl. Trop. Dis."},{"key":"53916_CR32","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/infdis\/jit273","volume":"208","author":"S Olkowski","year":"2013","unstructured":"Olkowski, S. et al. Reduced risk of disease during postsecondary dengue virus infections. J. Infect. Dis. 208, 1026\u20131033 (2013).","journal-title":"J. Infect. Dis."},{"key":"53916_CR33","doi-asserted-by":"publisher","first-page":"108226","DOI":"10.1016\/j.celrep.2020.108226","volume":"33","author":"DR Martinez","year":"2020","unstructured":"Martinez, D. R. et al. Antigenic variation of the Dengue virus 2 genotypes impacts the neutralization activity of human antibodies in vaccinees. Cell Rep. 33, 108226 (2020).","journal-title":"Cell Rep."},{"key":"53916_CR34","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/infdis\/jiu481","volume":"211","author":"KS Corbett","year":"2014","unstructured":"Corbett, K. S. et al. Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent Dengue virus infections in a Sri Lankan pediatric cohort. J. Infect. Dis. 211, 590\u2013599 (2014).","journal-title":"J. Infect. Dis."},{"key":"53916_CR35","doi-asserted-by":"publisher","first-page":"e2462","DOI":"10.1371\/journal.pntd.0002462","volume":"7","author":"A Gordon","year":"2013","unstructured":"Gordon, A. et al. The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004-2010. PLoS Negl. Trop. Dis. 7, e2462 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"53916_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41564-023-01543-3","volume":"9","author":"M Hamins-Puertolas","year":"2024","unstructured":"Hamins-Puertolas, M. et al. Household immunity and individual risk of infection with dengue virus in a prospective, longitudinal cohort study. Nat. Microbiol. 9, 274\u2013283 (2024).","journal-title":"Nat. Microbiol."},{"key":"53916_CR37","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1128\/JCM.43.10.4977-4983.2005","volume":"43","author":"BW Johnson","year":"2005","unstructured":"Johnson, B. W., Russell, B. J. & Lanciotti, R. S. Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J. Clin. Microbiol. 43, 4977\u20134983 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"53916_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jtm\/taz078","volume":"26","author":"M Bonaparte","year":"2019","unstructured":"Bonaparte, M. et al. Evaluation of rapid diagnostic tests and conventional enzyme-linked immunosorbent assays to determine prior dengue infection. J. Travel Med. 26, 1\u201311 (2019).","journal-title":"J. Travel Med."},{"key":"53916_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty percent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"53916_CR40","doi-asserted-by":"publisher","first-page":"e00386","DOI":"10.1128\/mbio.00386-22","volume":"13","author":"LV Tse","year":"2022","unstructured":"Tse, L. V. et al. Generation of mature DENVs via genetic modification and directed evolution. mBio 13, e00386\u201300322 (2022).","journal-title":"mBio"},{"key":"53916_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.virol.2016.06.022","volume":"497","author":"S Mukherjee","year":"2016","unstructured":"Mukherjee, S. et al. Enhancing dengue virus maturation using a stable furin over-expressing cell line. Virology 497, 33\u201340 (2016).","journal-title":"Virology"},{"key":"53916_CR42","doi-asserted-by":"publisher","first-page":"e0006862","DOI":"10.1371\/journal.pntd.0006862","volume":"12","author":"LC Katzelnick","year":"2018","unstructured":"Katzelnick, L. C. et al. Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus. PLoS Negl. Trop. Dis. 12, e0006862 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"53916_CR43","doi-asserted-by":"publisher","unstructured":"Hein Dahora, L. et al. Flavivirus serologic surveillance: Multiplex sample-sparing assay for detecting type-specific antibodies to Zika and Dengue viruses. Preprint at https:\/\/doi.org\/10.2139\/ssrn.4411430 (2023).","DOI":"10.2139\/ssrn.4411430"},{"key":"53916_CR44","doi-asserted-by":"publisher","first-page":"e2357","DOI":"10.1371\/journal.pntd.0002357","volume":"7","author":"M Montoya","year":"2013","unstructured":"Montoya, M. et al. Symptomatic versus inapparent outcome in repeat Dengue virus infections is influenced by the time interval between infections and study year. PLOS Negl. Trop.Dis. 7, e2357 (2013).","journal-title":"PLOS Negl. Trop.Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53916-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53916-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53916-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T10:03:01Z","timestamp":1735898581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53916-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["53916"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-53916-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4145863\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.Y., M.V.C., J.V.D., K.A.A., A.M.C. and A.K.S. report receiving salaries from 2017 onwards as part of an ongoing separate study (effectiveness of the tetravalent dengue vaccine, CYD-TDV [Dengvaxia] in the Philippines) sponsored by the University of the Philippines Manila and funded by Sanofi Pasteur. J.D. was an unpaid external consultant in the Extended Study Group for dengue vaccine effectiveness evaluation studies in Asia in 2015 convened by Sanofi Pasteur and is an unpaid investigator of an ongoing separate study (effectiveness of the tetravalent dengue vaccine, CYD-TDV [Dengvaxia] in the Philippines) sponsored by the University of the Philippines Manila and funded by Sanofi Pasteur. The protocol was written to evaluate the effect of the Sanofi Pasteur Dengvaxia vaccine. However, only unvaccinated individuals were included in the present manuscript. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"J.D., M.Y., J.V.D., M.V.C., and K.A.A. are investigators local to the Philippines who designed and established the cohort and collected all the demographic, clinical, and blood samples, and generated the enzyme-linked immunosorbent assay data. All local investigators were included in discussions of this work evaluating antibodies as correlates, roles, and responsibilities were agreed upon ahead of the research, and authorship was determined accordingly. This research is highly relevant to Cebu, Philippines, given the heavy local burden of disease, and this work was funded, in large part, by the Philippine Department of Health. Capacity building included additional training for JVD in the laboratory AMDS. This research did not result in stigmatization, incrimination, discrimination, or otherwise personal risk to participants. Related work by the local investigators has been cited appropriately here<sup>23,24<\/sup>.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"191"}}